
Glimipack MP 1mg/500mg/15mg Tablet
Marketer
Koye Pharmaceuticals Pvt ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glimipack MP 1mg/500mg/15mg Tablet
Metformin/Glibenclamide/Pioglitazone 1mg/500mg/15mg tablets are a triple-combination medication managing blood glucose. This regimen, used alongside diet and exercise, enhances glycemic control in adults with type 2 diabetes. It improves insulin effectiveness, thus reducing blood sugar. Dosage and duration should strictly follow your physician's instructions. Take with food to minimize stomach irritation. If a dose is missed, take it promptly unless the next dose is imminent; then omit the missed dose. Never double the dose. Overdosing can cause dangerously low blood sugar (hypoglycemia). Concomitant use with other diabetes medications, alcohol, or skipped meals increases hypoglycemia risk; regular blood glucose monitoring is vital. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Patients with kidney, liver, or heart conditions should inform their doctor before commencing treatment, as should pregnant or breastfeeding individuals. Kidney function tests are typically conducted before treatment begins. Limit alcohol consumption as it may heighten side effect risk.
Uses of Glimipack MP 1mg/500mg/15mg Tablet
Managing type 2 diabetes
Major Benefits of Glimipack MP 1mg/500mg/15mg Tablet:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Ingest the entire tablet without chewing, crushing, or fracturing it. Glimipack MP 1mg/500mg/15mg tablets should be taken with a meal.
Common Side effects of Glimipack MP 1mg/500mg/15mg Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glimipack MP 1mg/500mg/15mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Glimipack MP 1mg/500mg/15mg Tablet should be administered with a meal.
How Glimipack MP 1mg/500mg/15mg Tablet works:
Glimipack MP 1mg/500mg/15mg tablets contain glimepiride, metformin, and pioglitazone, three antidiabetic agents with distinct actions. This triple combination improves blood sugar management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release to reduce blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity. Pioglitazone, a thiazolidinedione, further augments insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Glimipack MP 1mg/500mg/15mg tablets is dangerous.
PregnancyCONSULT YOUR DOCTOR
Using Glimipack MP 1mg/500mg/15mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Glimipack MP 1mg/500mg/15mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Impaired driving is possible with both hypo- and hyperglycemia. Refrain from driving if these conditions arise.
KidneyCAUTION
Patients with kidney impairment should use Glimipack MP 1mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. Physician consultation is necessary. The medication is contraindicated in individuals with severe kidney disease. Regular kidney function monitoring is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Glimipack MP 1mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. Medical advice is necessary. The use of Glimipack MP 1mg/500mg/15mg tablets is contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Glimipack MP 1mg/500mg/15mg Tablet :
Should you forget to take a Glimipack MP 1mg/500mg/15mg Tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Glimipack MP 1mg/500mg/15mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
